
Guardian Metal Resources proposes Nevada spin‑out for 2027 AIM listing
Guardian expects to retain a significant stake in the new company and is not announcing a share distribution to existing holders.

The Nevada project retains late-2027 mechanical completion and a 2028 production ramp-up, with capital needs expected to remain funded.

Guardian expects to retain a significant stake in the new company and is not announcing a share distribution to existing holders.

Southern Cross Diagnostics can supply the DPYD assay for clinical use, but Novacyt has not dated its Australian commercial rollout.
Full production is targeted for 2028, with Louisiana offering a performance-based grant and the company planning 175 additional jobs.
Contracted GPU-cloud run rate includes undeployed capacity, while HIVE's year-end expansion target remains conditional on financing.

Canada and Germany have completed competition reviews, Curaleaf says, while its offer remains outstanding until Dec. 4.

Weekly brelovitug achieved a 59 per cent combined response, and Mirum plans an FDA filing in the first half of 2027.

Nine-month orders rose 611 per cent, but the third-quarter adjusted EBITDA loss widened to US$37.7 million.

Eight participants completed the placebo-controlled cohort; extension data are expected in January 2027 while a partial FDA hold remains.
True widths remain unknown as the first Skiråsen infill hole tests resource confidence at the wholly owned Swedish gold project.
Third-quarter capital investment rose to C$1.084 billion as higher costs outweighed gains from approved rates and peak demand.
The board accepted its committee's recommendation on Oct. 26, citing the harvest, a stronger outlook and debt repayment.
Phase 2 step-outs are testing the stock margins and undrilled ground ahead of a resource estimate planned for 2027.
Production is expected in 2029, subject to final government approvals, with flexibility to build hybrids, gasoline vehicles and EVs.
The sale targets a second-quarter 2027 close and supports additional debt reduction and an expanded share-repurchase plan.
The first phase is fully booked, but Telekom gives no commissioning date or contracted revenue for the added capacity.
Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.
View all
The copper-gold intercept lies about 55 metres down-dip of an earlier hole, supporting the company's eastern zone interpretation.
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
View all
The 86 per cent brain-response rate came from seven evaluable patients; lower-dose safety data are required before Phase 3.
Technology, computing, crypto and cannabis, and the listed companies moving in them.
View all
The first US$200 million draw awaits customer acceptance and other conditions, with borrowing at a minimum 8 per cent before fees.
All 53.40 bitcoin were pledged at Sept. 30, with US$5.05M of convertible debt due between January and April 2027.
Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.
View all
The power producer now expects adjusted earnings of US$12.50 to US$12.80 a share, lifting the midpoint by US$0.65.

BLM's completeness finding leaves pipeline baseline studies and the level of environmental review to be settled before mine-plan approval.

The nonbinding terms cover about 2 gigawatts, while the regulated capital plan requires US$3 billion in additional equity.
Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.
View all
Operating cash flow reached US$9.5 million as expansion spending eased, but weaker Canadian wholesale pricing reduced cannabis profit.

Free cash outflow narrowed to C$15.5 million as international sales grew, while charges on Canopy USA assets weighed on earnings.

Quarterly losses narrowed, but operating income fell and September-end financial statements show US$41.2 million in cash plus restricted funds.

The proposed common stamp would reduce the number of stamp types from 13 to six, with a Jan. 1, 2028 start date and no company savings estimate.